The global market for Veterinary Regenerative Medicine was valued at US$ 335 million in the year 2024 and is projected to reach a revised size of US$ 760 million by 2031, growing at a CAGR of 12.6% during the forecast period.

Veterinary Regenerative Medicine Market

Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types.

Regenerative medicine therapy has grown in popularity in both human and veterinary medicine for the treatment of a variety of disease conditions. In the rapidly developing field of veterinary regenerative medicine, cells, and tissues-such as live cells, serum, or bone-are utilized in animals with the hopes of restoring diseased or damaged tissues or organs. Recent studies have shown that it is effective in controlling a variety of orthopedic disorders in companion animals, including osteoarthritis and soft tissue injuries. Regenerative medicine is increasingly used as an alternative to surgical, medicinal, and rehabilitation therapy or as a multimodal approach to treating a condition or injury.

This report aims to provide a comprehensive presentation of the global market for Veterinary Regenerative Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Regenerative Medicine.

The Veterinary Regenerative Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Regenerative Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Veterinary Regenerative Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Veterinary Regenerative Medicine Market Report

Report Metric	Details
Report Name	Veterinary Regenerative Medicine Market
Accounted market size in year	US$ 335 million
Forecasted market size in 2031	US$ 760 million
CAGR	12.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Platelet-Rich Plasma (PRP) Stem Cell Therapy Others
Segment by Application	Veterinary Hospitals/Clinics Veterinary Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ACell Inc. (Integra LifeSciences), Animal Cell Therapies, Inc., Ardent, Boehringer Ingelheim International GmbH, Cell Therapy Sciences, Dechra, Enso Discoveries, South Paws Veterinary Surgical Specialists, Veterinary Specialty Center, Vetbiologics, Vetherapy, VetStem, Inc., Zoetis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Regenerative Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Veterinary Regenerative Medicine Market growing?

Ans: The Veterinary Regenerative Medicine Market witnessing a CAGR of 12.6% during the forecast period 2025-2031.

What is the Veterinary Regenerative Medicine Market size in 2031?

Ans: The Veterinary Regenerative Medicine Market size in 2031 will be US$ 760 million.

Who are the main players in the Veterinary Regenerative Medicine Market report?

Ans: The main players in the Veterinary Regenerative Medicine Market are ACell Inc. (Integra LifeSciences), Animal Cell Therapies, Inc., Ardent, Boehringer Ingelheim International GmbH, Cell Therapy Sciences, Dechra, Enso Discoveries, South Paws Veterinary Surgical Specialists, Veterinary Specialty Center, Vetbiologics, Vetherapy, VetStem, Inc., Zoetis

What are the Application segmentation covered in the Veterinary Regenerative Medicine Market report?

Ans: The Applications covered in the Veterinary Regenerative Medicine Market report are Veterinary Hospitals/Clinics, Veterinary Research Institutes

What are the Type segmentation covered in the Veterinary Regenerative Medicine Market report?

Ans: The Types covered in the Veterinary Regenerative Medicine Market report are Platelet-Rich Plasma (PRP), Stem Cell Therapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Veterinary Regenerative Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Platelet-Rich Plasma (PRP)

1.2.3 Stem Cell Therapy

1.2.4 Others

1.3 Market by Application

1.3.1 Global Veterinary Regenerative Medicine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Veterinary Hospitals/Clinics

1.3.3 Veterinary Research Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Veterinary Regenerative Medicine Market Perspective (2020-2031)

2.2 Global Veterinary Regenerative Medicine Growth Trends by Region

2.2.1 Global Veterinary Regenerative Medicine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Veterinary Regenerative Medicine Historic Market Size by Region (2020-2025)

2.2.3 Veterinary Regenerative Medicine Forecasted Market Size by Region (2026-2031)

2.3 Veterinary Regenerative Medicine Market Dynamics

2.3.1 Veterinary Regenerative Medicine Industry Trends

2.3.2 Veterinary Regenerative Medicine Market Drivers

2.3.3 Veterinary Regenerative Medicine Market Challenges

2.3.4 Veterinary Regenerative Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Veterinary Regenerative Medicine Players by Revenue

3.1.1 Global Top Veterinary Regenerative Medicine Players by Revenue (2020-2025)

3.1.2 Global Veterinary Regenerative Medicine Revenue Market Share by Players (2020-2025)

3.2 Global Veterinary Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Veterinary Regenerative Medicine Revenue

3.4 Global Veterinary Regenerative Medicine Market Concentration Ratio

3.4.1 Global Veterinary Regenerative Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Veterinary Regenerative Medicine Revenue in 2024

3.5 Global Key Players of Veterinary Regenerative Medicine Head office and Area Served

3.6 Global Key Players of Veterinary Regenerative Medicine, Product and Application

3.7 Global Key Players of Veterinary Regenerative Medicine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Veterinary Regenerative Medicine Breakdown Data by Type

4.1 Global Veterinary Regenerative Medicine Historic Market Size by Type (2020-2025)

4.2 Global Veterinary Regenerative Medicine Forecasted Market Size by Type (2026-2031)

5 Veterinary Regenerative Medicine Breakdown Data by Application

5.1 Global Veterinary Regenerative Medicine Historic Market Size by Application (2020-2025)

5.2 Global Veterinary Regenerative Medicine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Veterinary Regenerative Medicine Market Size (2020-2031)

6.2 North America Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Veterinary Regenerative Medicine Market Size by Country (2020-2025)

6.4 North America Veterinary Regenerative Medicine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Veterinary Regenerative Medicine Market Size (2020-2031)

7.2 Europe Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Veterinary Regenerative Medicine Market Size by Country (2020-2025)

7.4 Europe Veterinary Regenerative Medicine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Veterinary Regenerative Medicine Market Size (2020-2031)

8.2 Asia-Pacific Veterinary Regenerative Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2020-2025)

8.4 Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Veterinary Regenerative Medicine Market Size (2020-2031)

9.2 Latin America Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Veterinary Regenerative Medicine Market Size by Country (2020-2025)

9.4 Latin America Veterinary Regenerative Medicine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Veterinary Regenerative Medicine Market Size (2020-2031)

10.2 Middle East & Africa Veterinary Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2020-2025)

10.4 Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ACell Inc. (Integra LifeSciences)

11.1.1 ACell Inc. (Integra LifeSciences) Company Details

11.1.2 ACell Inc. (Integra LifeSciences) Business Overview

11.1.3 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Introduction

11.1.4 ACell Inc. (Integra LifeSciences) Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.1.5 ACell Inc. (Integra LifeSciences) Recent Development

11.2 Animal Cell Therapies, Inc.

11.2.1 Animal Cell Therapies, Inc. Company Details

11.2.2 Animal Cell Therapies, Inc. Business Overview

11.2.3 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Introduction

11.2.4 Animal Cell Therapies, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.2.5 Animal Cell Therapies, Inc. Recent Development

11.3 Ardent

11.3.1 Ardent Company Details

11.3.2 Ardent Business Overview

11.3.3 Ardent Veterinary Regenerative Medicine Introduction

11.3.4 Ardent Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.3.5 Ardent Recent Development

11.4 Boehringer Ingelheim International GmbH

11.4.1 Boehringer Ingelheim International GmbH Company Details

11.4.2 Boehringer Ingelheim International GmbH Business Overview

11.4.3 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Introduction

11.4.4 Boehringer Ingelheim International GmbH Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.4.5 Boehringer Ingelheim International GmbH Recent Development

11.5 Cell Therapy Sciences

11.5.1 Cell Therapy Sciences Company Details

11.5.2 Cell Therapy Sciences Business Overview

11.5.3 Cell Therapy Sciences Veterinary Regenerative Medicine Introduction

11.5.4 Cell Therapy Sciences Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.5.5 Cell Therapy Sciences Recent Development

11.6 Dechra

11.6.1 Dechra Company Details

11.6.2 Dechra Business Overview

11.6.3 Dechra Veterinary Regenerative Medicine Introduction

11.6.4 Dechra Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.6.5 Dechra Recent Development

11.7 Enso Discoveries

11.7.1 Enso Discoveries Company Details

11.7.2 Enso Discoveries Business Overview

11.7.3 Enso Discoveries Veterinary Regenerative Medicine Introduction

11.7.4 Enso Discoveries Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.7.5 Enso Discoveries Recent Development

11.8 South Paws Veterinary Surgical Specialists

11.8.1 South Paws Veterinary Surgical Specialists Company Details

11.8.2 South Paws Veterinary Surgical Specialists Business Overview

11.8.3 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Introduction

11.8.4 South Paws Veterinary Surgical Specialists Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.8.5 South Paws Veterinary Surgical Specialists Recent Development

11.9 Veterinary Specialty Center

11.9.1 Veterinary Specialty Center Company Details

11.9.2 Veterinary Specialty Center Business Overview

11.9.3 Veterinary Specialty Center Veterinary Regenerative Medicine Introduction

11.9.4 Veterinary Specialty Center Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.9.5 Veterinary Specialty Center Recent Development

11.10 Vetbiologics

11.10.1 Vetbiologics Company Details

11.10.2 Vetbiologics Business Overview

11.10.3 Vetbiologics Veterinary Regenerative Medicine Introduction

11.10.4 Vetbiologics Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.10.5 Vetbiologics Recent Development

11.11 Vetherapy

11.11.1 Vetherapy Company Details

11.11.2 Vetherapy Business Overview

11.11.3 Vetherapy Veterinary Regenerative Medicine Introduction

11.11.4 Vetherapy Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.11.5 Vetherapy Recent Development

11.12 VetStem, Inc.

11.12.1 VetStem, Inc. Company Details

11.12.2 VetStem, Inc. Business Overview

11.12.3 VetStem, Inc. Veterinary Regenerative Medicine Introduction

11.12.4 VetStem, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.12.5 VetStem, Inc. Recent Development

11.13 Zoetis

11.13.1 Zoetis Company Details

11.13.2 Zoetis Business Overview

11.13.3 Zoetis Veterinary Regenerative Medicine Introduction

11.13.4 Zoetis Revenue in Veterinary Regenerative Medicine Business (2020-2025)

11.13.5 Zoetis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ardent

Boehringer Ingelheim International GmbH

Cell Therapy Sciences

ACell Inc. (Integra LifeSciences)

Animal Cell Therapies, Inc.

South Paws Veterinary Surgical Specialists

Veterinary Specialty Center

Vetherapy

List of Tables

Table 1. Global Veterinary Regenerative Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Platelet-Rich Plasma (PRP)

Table 3. Key Players of Stem Cell Therapy

Table 4. Key Players of Others

Table 5. Global Veterinary Regenerative Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Veterinary Regenerative Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Veterinary Regenerative Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Veterinary Regenerative Medicine Market Share by Region (2020-2025)

Table 9. Global Veterinary Regenerative Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Veterinary Regenerative Medicine Market Share by Region (2026-2031)

Table 11. Veterinary Regenerative Medicine Market Trends

Table 12. Veterinary Regenerative Medicine Market Drivers

Table 13. Veterinary Regenerative Medicine Market Challenges

Table 14. Veterinary Regenerative Medicine Market Restraints

Table 15. Global Veterinary Regenerative Medicine Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Veterinary Regenerative Medicine Market Share by Players (2020-2025)

Table 17. Global Top Veterinary Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Regenerative Medicine as of 2024)

Table 18. Ranking of Global Top Veterinary Regenerative Medicine Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Veterinary Regenerative Medicine Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Veterinary Regenerative Medicine, Headquarters and Area Served

Table 21. Global Key Players of Veterinary Regenerative Medicine, Product and Application

Table 22. Global Key Players of Veterinary Regenerative Medicine, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Veterinary Regenerative Medicine Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Veterinary Regenerative Medicine Revenue Market Share by Type (2020-2025)

Table 26. Global Veterinary Regenerative Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Veterinary Regenerative Medicine Revenue Market Share by Type (2026-2031)

Table 28. Global Veterinary Regenerative Medicine Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Veterinary Regenerative Medicine Revenue Market Share by Application (2020-2025)

Table 30. Global Veterinary Regenerative Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Veterinary Regenerative Medicine Revenue Market Share by Application (2026-2031)

Table 32. North America Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Veterinary Regenerative Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Veterinary Regenerative Medicine Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Veterinary Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Veterinary Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 47. ACell Inc. (Integra LifeSciences) Company Details

Table 48. ACell Inc. (Integra LifeSciences) Business Overview

Table 49. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product

Table 50. ACell Inc. (Integra LifeSciences) Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 51. ACell Inc. (Integra LifeSciences) Recent Development

Table 52. Animal Cell Therapies, Inc. Company Details

Table 53. Animal Cell Therapies, Inc. Business Overview

Table 54. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product

Table 55. Animal Cell Therapies, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 56. Animal Cell Therapies, Inc. Recent Development

Table 57. Ardent Company Details

Table 58. Ardent Business Overview

Table 59. Ardent Veterinary Regenerative Medicine Product

Table 60. Ardent Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 61. Ardent Recent Development

Table 62. Boehringer Ingelheim International GmbH Company Details

Table 63. Boehringer Ingelheim International GmbH Business Overview

Table 64. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product

Table 65. Boehringer Ingelheim International GmbH Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 66. Boehringer Ingelheim International GmbH Recent Development

Table 67. Cell Therapy Sciences Company Details

Table 68. Cell Therapy Sciences Business Overview

Table 69. Cell Therapy Sciences Veterinary Regenerative Medicine Product

Table 70. Cell Therapy Sciences Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 71. Cell Therapy Sciences Recent Development

Table 72. Dechra Company Details

Table 73. Dechra Business Overview

Table 74. Dechra Veterinary Regenerative Medicine Product

Table 75. Dechra Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 76. Dechra Recent Development

Table 77. Enso Discoveries Company Details

Table 78. Enso Discoveries Business Overview

Table 79. Enso Discoveries Veterinary Regenerative Medicine Product

Table 80. Enso Discoveries Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 81. Enso Discoveries Recent Development

Table 82. South Paws Veterinary Surgical Specialists Company Details

Table 83. South Paws Veterinary Surgical Specialists Business Overview

Table 84. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product

Table 85. South Paws Veterinary Surgical Specialists Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 86. South Paws Veterinary Surgical Specialists Recent Development

Table 87. Veterinary Specialty Center Company Details

Table 88. Veterinary Specialty Center Business Overview

Table 89. Veterinary Specialty Center Veterinary Regenerative Medicine Product

Table 90. Veterinary Specialty Center Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 91. Veterinary Specialty Center Recent Development

Table 92. Vetbiologics Company Details

Table 93. Vetbiologics Business Overview

Table 94. Vetbiologics Veterinary Regenerative Medicine Product

Table 95. Vetbiologics Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 96. Vetbiologics Recent Development

Table 97. Vetherapy Company Details

Table 98. Vetherapy Business Overview

Table 99. Vetherapy Veterinary Regenerative Medicine Product

Table 100. Vetherapy Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 101. Vetherapy Recent Development

Table 102. VetStem, Inc. Company Details

Table 103. VetStem, Inc. Business Overview

Table 104. VetStem, Inc. Veterinary Regenerative Medicine Product

Table 105. VetStem, Inc. Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 106. VetStem, Inc. Recent Development

Table 107. Zoetis Company Details

Table 108. Zoetis Business Overview

Table 109. Zoetis Veterinary Regenerative Medicine Product

Table 110. Zoetis Revenue in Veterinary Regenerative Medicine Business (2020-2025) & (US$ Million)

Table 111. Zoetis Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Veterinary Regenerative Medicine Picture

Figure 2. Global Veterinary Regenerative Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Veterinary Regenerative Medicine Market Share by Type: 2024 VS 2031

Figure 4. Platelet-Rich Plasma (PRP) Features

Figure 5. Stem Cell Therapy Features

Figure 6. Others Features

Figure 7. Global Veterinary Regenerative Medicine Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Veterinary Regenerative Medicine Market Share by Application: 2024 VS 2031

Figure 9. Veterinary Hospitals/Clinics Case Studies

Figure 10. Veterinary Research Institutes Case Studies

Figure 11. Veterinary Regenerative Medicine Report Years Considered

Figure 12. Global Veterinary Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Veterinary Regenerative Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Veterinary Regenerative Medicine Market Share by Region: 2024 VS 2031

Figure 15. Global Veterinary Regenerative Medicine Market Share by Players in 2024

Figure 16. Global Top Veterinary Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Regenerative Medicine as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Veterinary Regenerative Medicine Revenue in 2024

Figure 18. North America Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Veterinary Regenerative Medicine Market Share by Country (2020-2031)

Figure 20. United States Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Veterinary Regenerative Medicine Market Share by Country (2020-2031)

Figure 24. Germany Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Veterinary Regenerative Medicine Market Share by Region (2020-2031)

Figure 32. China Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Veterinary Regenerative Medicine Market Share by Country (2020-2031)

Figure 40. Mexico Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Veterinary Regenerative Medicine Market Share by Country (2020-2031)

Figure 44. Turkey Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Veterinary Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. ACell Inc. (Integra LifeSciences) Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 48. Animal Cell Therapies, Inc. Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 49. Ardent Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 50. Boehringer Ingelheim International GmbH Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 51. Cell Therapy Sciences Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 52. Dechra Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 53. Enso Discoveries Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 54. South Paws Veterinary Surgical Specialists Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 55. Veterinary Specialty Center Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 56. Vetbiologics Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 57. Vetherapy Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 58. VetStem, Inc. Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 59. Zoetis Revenue Growth Rate in Veterinary Regenerative Medicine Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions